Table 3.

Antimicrobial resistance patterns of clinically relevant bacterial isolates from wound infection in Ethiopia

Types of Bacteria	Studies	Number of isolates	Number of isolates resistant to
			AMO	AMC	AMP	CIP	CRO	SXT	ERY	GEN	MET
S. aureus	Abraham and Wamisho	24	9	6	20	4	2	6	2	3	5
	Alebachew et al	66	–	22	–	–	23	–	9	–	51
	Asres et al.	56	–	9	–	7	–	19	9	7	6
	Azene et al	208	165	–	–	18	37	140	72	26	22
	Bitew et al	110	–	–	–	7	–	30	70	2	–
	Kiflie et al	42	28	–	30	–	15	26	–	–	22
	Desalegn et al	66		20	63	26	54	37	29	26	–
	Dessie et al	19	–	–	–	3	–	4	4	3	–
	Godebo et al	73	–	–	67	10	15	44	58	12	57
	Guta et al	45	45	–	–	–	16	–	–	9	–
	Hailu et al	NDA	–	–	–	5(67)	–	16 (94)	30 (96)	–	20 (95)
	Kahsay et al	73	13	–	13	–	–	1	–	9	36
	Lema et al	68	45	8	58	6	–	23	20	5	50
	Mama et al	47	–	–	45	2	7	3	7	2	–
	Mengesha et al	40	37	20	36	–	36	–	9	4	34
	Mohammed et al	39	34	–	–	8	8	15	24	7	30
	Mulu et al., 2006	51	–	–	28	–	–	18	–	–	–
CoNS	Abraham and Wamisho	12	1	–	4	1	1	–	1	2
	Asres et al.	19	–	15	–	5	–	14	11	12
	Kiflie et al	13	11	–	11	–	5	8	–	–
	Desalegn et al	6	–	3	6	3	6	3	3	3
	Dessie et al	4	–	–	–	4	–	3	3	3
	Godebo et al	14	–	–	9	0	2	5	0	0
	Guta et al	26	4	–	–	–	13	–	–	13
	Lema et al	18	6	–	12	1	–	9	9	3
	Mama et al	21	–	–	19	5	6	3	8	4
	Mengesha et al	18	16	14	14	–	13	–	9	9
	Mohammed et al	16	13	–	–	3	8	7	8	3
E. coli	Abraham and Wamisho	17	8	4	7	1	2	5	–	2
	Asres et al.	24	20	14	–	5	–	15	–	7
	Azene et al	82	70	–	–	21	55	55	43	12
	Bitew et al	49	–	35	35	5	10	22	–	5
	Kiflie et al	20	14	–	16	4	12	10	–	7
	Desalegn et al	45	–	21	45	18	18	27	–	21
	Dessie et al	24	–	17	23	16	20	–	–	13
	Godebo et al	30	–	–	23	1	20	6	–	0
	Guta et al	30	20	–	–	–	10	–	–	0
	Hailu et al	NDA	–	24 (33)	31 (33)	15 (33)	6 (24)	23 (30)	–	18 (33)
	Lema et al	14	10	7	9	–	–	9	–	–
	Mama et al	29	–	–	29	10	18	16	–	15
	Mengesha et al	6	4	6	6	1	4	–	2	–
	Mohammed et al	8	–	–	6	3	1	4	–	1
	Mulu et al., 2006	8	–	–	7	–	–	5	–	–
P. aeruginosa	Abraham and Wamisho	16	13	13	14	0	5	11	–	2
	Asres et al.	8	8	7	–	1	–	7	–	2
	Azene et al	92	76	–	–	4	47	71	83	7
	Bitew et al	14	–	14	14	1	11	9	–	1
	Desalegn et al	18	–	18	18	0	18	12	–	9
	Dessie et al	6	–	6	6	2	5	–	–	0
	Godebo et al	74	–	–	72	4	7	65	–	8
	Guta et al	16	16	–	–	–	8	–	–	8
	Hailu et al	NDA	–	–	–	5 (26)	–	3 (9)	–	7 (23)
	Lema et al	7	6	7	6	–	–	7	–	1
	Mama et al	11	–	–	11	–	7	8	–	2
	Mengesha et al	11	11	11	11	9	11	–	3	–
	Mohammed et al	8	–	–	–	3	3	–	–	3
	Tekie	8	–	–	–	6	4	7	–	3
K. pneumoniae	Abraham and Wamisho	12	8	4	12	0	3	3	–	3
	Asres et al.	15	14	12	–	4	13	13	–	9
	Azene et al	12	12	–	–	–	–	8	–	0
	Bitew et al	12	–	12	12	2	7	5	–	2
	Kiflie et al	14	14	–	14	2	8	9	–	3
	Desalegn et al	24	–	12	21	15	21	21	–	24
	Dessie et al	10	–	10	10	2	9	–	–	4
	Godebo et al	46	–	–	32	13	13	30	–	13
	Guta et al	32	25	–	–	–	9	–	–	12
	Hailu et al	NDA	–	10 (20)	15 (20)	4 (20)	2 (18)	8 (20)	–	11 (18)
	Mama et al	14	–	–	14	5	10	12	–	9
	Mengesha et al	29	29	19	26	11	25	–	13	8
	Mohammed et al	17	–	–	16	10	9	11	–	5
P. mirabilis	Abraham and Wamisho	6	2	1	1	0	0	3	–	0
	Azene et al	55	48	–	–	9	35	45	51	5
	Bitew et al	7	–	4	5	2	5	5	–	2
	Desalegn et al	18	–	9	18	0	6	3	–	6
	Godebo et al	107	–	–	77	8	8	81	–	35
	Guta et al	12	11	–	–	–	8	–	–	6
	Hailu et al	NDA	–	12 (22)	17 (22)	5 (22)	8 (18)	7 (17)	–	5 (22)
	Lema et al	47	24	20	31	4	–	21	–	4
	Mama et al	23	–	–	21	4	15	9	–	6
	Mengesha et al	15	15	7	13	7	11	–	9	3
	Mohammed et al	6	–	–	6	2	1	5	–	2

---, Not tested, NDA Number of isolates is different among antimicrobial agents tested as indicated in parenthesis of the corresponding rows, AMO Amoxicillin, AMP Ampicillin, AMC Amoxicillin-clavulanic acid, SXT Cotrimoxazole, CRO Ceftriaxone, CIP Ciprofloxacin, GEN Gentamicin, ERY Erythromycin